Showing results (761-770 of 1,628) with videos related to
Sort By:
Pageof 163
Cardio-Oncology (London, England)|March 12, 2022
Cardiotoxicity risk factors with immune checkpoint inhibitorsZachary L Brumberger, Mary E Branch, Max W Klein, et al.Chest|February 12, 2000
The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilizationM H Kollef, S D Shapiro, D Clinkscale, et al.Circulation Research|September 2, 2000
Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardiumN I Moldovan, P J Goldschmidt-Clermont, J Parker-Thornburg, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 28, 2007
Comprehensive cardiac CT study: evaluation of coronary arteries, left ventricular function, and myocardial perfusion--is it possible?Ricardo C Cury, Koen Nieman, Michael D Shapiro, et al.Journal of Epidemiology and Community Health|June 26, 2016
Paternal education and adverse birth outcomes in CanadaGabriel D Shapiro, Tracey Bushnik, Amanda J Sheppard, et al.Plos One|August 27, 2013
A Val85Met mutation in melanocortin-1 receptor is associated with reductions in eumelanic pigmentation and cell surface expression in domestic rock pigeons (Columba livia)Michael W Guernsey, Lars Ritscher, Matthew A Miller, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2026
Alveolar epithelial NF-κB/RelA guards the lung against bacterial infectionHongqiao Zhang, Yadong Xiao, Feng Gao, et al.Health Reports|December 22, 2016
Missing paternal data and adverse birth outcomes in CanadaGabriel D Shapiro, Tracey Bushnik, Amanda J Sheppard, et al.BMJ Open|February 6, 2026
Association between severe maternal morbidity and health service use in the first postpartum year: a population-based retrospective cohort study in British Columbia, CanadaLauren Tanner, Sarka Lisonkova, Gabriel D Shapiro, et al.Virchows Archiv : an International Journal of Pathology|July 16, 2026
GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterationsQinyuan Li, Anupama Singh, Rong Hu, et al.Pageof 163